AEON Biopharma

AEON · NASDAQ

$0.2315+$0.0005 (+0.22%)TodayMarket closed ·
Prev close $0.231

Latest news

  • Press releaseGlobe Newswire

    AEON Biopharma FDA Type 2b Meeting Feedback Clarifies Biosimilar Development Plan for ABP-450

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    AEON Biopharma Designates Paul Lee As Chief Regulatory Office

  • Press releaseGlobe Newswire

    AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releaseGlobe Newswire

    AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX®

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • Press releaseGlobe Newswire

    AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

  • Press releaseGlobe Newswire

    AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releaseGlobe Newswire

    AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding

  • Press releaseGlobe Newswire

    AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • News

    AEON Biopharma Q1 EPS $(0.29) Misses $(0.13) Estimate

  • Press releaseGlobe Newswire

    AEON Biopharma Reports First Quarter 2026 Financial Results and Provides Corporate Update

  • Press releaseGlobe Newswire

    AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards

  • News

    AEON Biopharma Q4 EPS $(3.72)

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • NewsAvi Kapoor

    Dow Jumps Over 300 Points; US Industrial Production Beats Estimates

  • NewsAvi Kapoor

    Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet

  • NewsAvi Kapoor

    S&P Jumps 1%; Regional Health Properties Shares Spike Higher

  • NewsHenry Khederian

    Why AEON Biopharma Stock Is Down 65% Today

  • NewsAvi Kapoor

    US Stocks Open Higher; Dow Jumps Over 200 Points

  • NewsAvi Kapoor

    Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.